-The United Nations The Asia-Pacific region, which has overtaken the rest of the world in consumption of raw materials as affluence and manufacturing increase, must boost its resource efficiency or risk losing ground in lifestyle, economic Growth and environmental sustainability, according to a UN report released today. From 1970-2008, consumption of construction minerals increased 13.4 times, metal ores and industrial minerals consumption 8.6, fossil fuels 5.4, and biomass 2.7 times, according to...

-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...

-The United Nations The United Nations today launched the Zero Hunger Challenge in Asia and the Pacific, calling on governments, farmers, scientists, business, civil society and consumers to work together to end hunger in the region where the majority of the world's undernourished people live. "Sustainable development and inclusive Growth will not happen on empty stomachs," said Noeleen Heyzer, Executive Secretary of the UN Economic and Social Commission for Asia and the...

-The Times of India NAGPUR: President Pranab Mukherjee on Monday slammed multinational companies saying they only looked for oversees locations with an intention to dodge taxes, raising eyebrows at a time when the country is desperately wooing foreign capital to plug a widening current account deficit. Addressing a function at the National Academy of Direct Taxes (NADT), Mukherjee said more than three-fourths of business transactions nowadays took place through the units of...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...